Recent advances in c-Met-based dual inhibitors in the treatment of cancers
European Journal of Medicinal Chemistry,
Год журнала:
2024,
Номер
272, С. 116477 - 116477
Опубликована: Май 8, 2024
Язык: Английский
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations
Journal of Molecular Structure,
Год журнала:
2024,
Номер
1309, С. 138148 - 138148
Опубликована: Март 26, 2024
Язык: Английский
Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights
Bioorganic Chemistry,
Год журнала:
2024,
Номер
153, С. 107804 - 107804
Опубликована: Сен. 6, 2024
Язык: Английский
Discovery of novel tris-1,2,3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction
Bioorganic Chemistry,
Год журнала:
2025,
Номер
155, С. 108131 - 108131
Опубликована: Янв. 8, 2025
Язык: Английский
Discovery of new 1,3-diphenylurea appended aryl pyridine derivatives as apoptosis inducers through c-MET and VEGFR-2 inhibition: design, synthesis, in vivo and in silico studies
RSC Medicinal Chemistry,
Год журнала:
2024,
Номер
15(7), С. 2553 - 2569
Опубликована: Янв. 1, 2024
A
new
1,3-diphenylurea
appended
aryl
pyridine
derivative
was
designed,
synthesized
and
characterized
as
c-MET
VEGFR-2
inhibitors
to
induce
apoptosis
against
MCF-7
cells.
Язык: Английский
Current scenario of pyrazole hybrids with anti‐breast cancer therapeutic applications
Archiv der Pharmazie,
Год журнала:
2024,
Номер
357(10)
Опубликована: Июнь 29, 2024
Breast
cancer
stands
as
the
leading
cause
of
cancer-related
deaths
among
women
globally,
but
current
therapy
is
restricted
to
serious
adverse
effects
and
multidrug
resistance,
necessitating
exploration
novel,
safe,
efficient
anti-breast
chemotherapeutic
agents.
Pyrazoles
exhibit
excellent
potential
for
utilization
effective
agents
due
their
ability
act
on
various
biological
targets.
Particularly,
pyrazole
hybrids
demonstrated
advantage
targeting
multiple
pathways,
some
them,
which
are
exemplified
by
larotrectinib
(pyrazolo[1,5-a]pyrimidine
hybrid),
can
be
applied
breast
therapy.
Thus,
hold
great
promise
useful
therapeutic
interventions
cancer.
The
aim
this
review
summarize
scenario
with
in
vitro
and/or
vivo
potential,
along
modes
action
structure-activity
relationships,
covering
articles
published
from
2020
present,
streamline
development
rational,
safe
candidates.
Язык: Английский
Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents
Bioorganic Chemistry,
Год журнала:
2024,
Номер
151, С. 107682 - 107682
Опубликована: Авг. 6, 2024
Язык: Английский
Cancer research in the United Arab Emirates from birth to present: A bibliometric analysis
Heliyon,
Год журнала:
2024,
Номер
10(6), С. e27201 - e27201
Опубликована: Март 1, 2024
BackgroundAccumulating
evidence
indicates
that
the
incidence
of
cancer
is
increasing
in
United
Arab
Emirates
(UAE).
This
analysis
aimed
to
determine
current
research
output
UAE
guide
future
national
research.MethodsThe
Scopus
database
was
searched
for
cancer-related
bibliographic
data
from
UAE.
The
number
publications,
citation
analysis,
co-authorship
author,
institution,
and
country,
keyword
co-occurrence,
reference
co-citations
were
analyzed
using
R-studio
bibliometrics
package
VOSviewer
software.ResultsA
total
1678
journal
articles
retrieved
1981
2022.
Cancer
(UCR)
at
a
rate
14.64%
(R-squared
=
0.75;
F
46.477;
P<0.001).
had
0.06%
participation
terms
original
articles.
international
40.23%.
U.S.A.,
U.K.,
Egypt,
Saudi
Arabia,
India,
Canada
more
than
100
co-authored
documents
156
countries
collaborated
with
U.A.E.ConclusionsCompared
other
nations,
has
fewer
publications
on
cancer,
although
growing.
report
provides
an
up-to-date
in-depth
summary
trends
UCR.
project
excellent
place
researchers
interested
conducting
data-mapping
work
this
field.
Язык: Английский
Synthesis of novel pyridine and pyrazolyl pyridine conjugates with potent cytotoxicity against HepG2 cancer cells as PIM-1 kinase inhibitors and caspase activators
RSC Advances,
Год журнала:
2024,
Номер
14(53), С. 39381 - 39394
Опубликована: Янв. 1, 2024
Novel
pyridine
and
pyrazolyl
derivatives
were
synthesized
characterized
with
potent
cytotoxicity
against
HepG2
cancer
cells
as
PIM-1
kinase
inhibitors
caspase
activators.
Язык: Английский